Clinical trial
The Impact of Dry Eye Syndrome on Novel Metrics of Low Contrast Vision Before and After Therapeutic Meibomian Gland Expression
NCT05713981 is registered in ClinicalTrials.gov with University of the Incarnate Word as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Dry Eye Syndrome on Novel Metrics of Low Contrast Vision Before and After Therapeutic Meibomian Gland Expression
- Lead sponsor
- University of the Incarnate Word
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2023
- Completion date
- June 8, 2023
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.